Metropolitan Life Insurance Company (MetLife)’s CleanSpark CLSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,178
Closed -$216K 442
2024
Q1
$216K Buy
10,178
+1,585
+18% +$22K 0.01% 687
2023
Q4
$94.8K Buy
8,593
+1,988
+30% +$12.4K ﹤0.01% 1113
2023
Q3
$25.2K Buy
6,605
+2,178
+49% +$11.5K ﹤0.01% 1778
2023
Q2
$19K Hold
4,427
﹤0.01% 1963
2023
Q1
$12.3K Buy
+4,427
New +$12.1K ﹤0.01% 2086
2022
Q3
Sell
-2,522
Closed -$9.89K 2316
2022
Q2
$9.89K Hold
2,522
﹤0.01% 2309
2022
Q1
$31.2K Sell
2,522
-8,294
-77% -$76.7K ﹤0.01% 1862
2021
Q4
$103K Hold
10,816
﹤0.01% 2459
2021
Q3
$125K Sell
10,816
-39
-0.4% -$525 ﹤0.01% 2392
2021
Q2
$181K Buy
+10,855
New +$199K ﹤0.01% 2224

Other funds holding CLSK

Metropolitan Life Insurance Company (MetLife)'s CLSK Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CleanSpark (CLSK) in Q2 2024, closing a stake of 10,178 shares — an estimated $216K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CLSK in Q2 2021 and held it in 10 quarters. The position peaked at $216K in Q1 2024. 243 funds tracked by Wall St. Rank hold CLSK as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CleanSpark position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 10,178 CleanSpark shares in Q2 2024, an estimated $216K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CleanSpark in Q2 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CleanSpark position peaked at $216K in Q1 2024.
  • 243 funds tracked by Wall St. Rank held CleanSpark as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.